Publication:
Increased endothelial microparticles and oxidative stress at extreme altitude.

cris.virtualsource.author-orcidf1bdb8ae-740c-4d7a-9040-bed65ffc5f91
cris.virtualsource.author-orcidb7988251-5b38-420e-9e0d-b124004c484f
cris.virtualsource.author-orcid12b41b39-91d9-4f4c-ba34-c51c7ef0a8f0
cris.virtualsource.author-orcidb45b7422-97de-484f-9a83-b0bf5fbacd4b
cris.virtualsource.author-orcid28c4cd0e-e650-430f-a6cd-f61ab642a95e
datacite.rightsopen.access
dc.contributor.authorPichler, Jacqueline
dc.contributor.authorLeichtle, Alexander Benedikt
dc.contributor.authorStutz, Monika
dc.contributor.authorHefti, Urs
dc.contributor.authorGeiser, Thomas
dc.contributor.authorHuber, Andreas R
dc.contributor.authorMerz, Tobias
dc.date.accessioned2024-10-24T16:36:20Z
dc.date.available2024-10-24T16:36:20Z
dc.date.issued2016-01-28
dc.description.abstractPURPOSE Hypoxia and oxidative stress affect endothelial function. Endothelial microparticles (MP) are established measures of endothelial dysfunction and influence vascular reactivity. To evaluate the effects of hypoxia and antioxidant supplementation on endothelial MP profiles, a double-blind, placebo-controlled trial, during a high altitude expedition was performed. METHODS 29 participants were randomly assigned to a treatment group (n = 14), receiving vitamin E, C, A, and N-acetylcysteine daily, and a control group (n = 15), receiving placebo. Blood samples were obtained at 490 m (baseline), 3530, 4590, and 6210 m. A sensitive tandem mass spectrometry method was used to measure 8-iso-prostaglandin F2α and hydroxyoctadecadienoic acids as markers of oxidative stress. Assessment of MP profiles including endothelial activation markers (CD62+MP and CD144+MP) and cell apoptosis markers (phosphatidylserine+MP and CD31+MP) was performed using a standardized flow cytometry-based protocol. RESULTS 15 subjects reached all altitudes and were included in the final analysis. Oxidative stress increased significantly at altitude. No statistically significant changes were observed comparing baseline to altitude measurements of phosphatidylserine expressing MP (p = 0.1718) and CD31+MP (p = 0.1305). Compared to baseline measurements, a significant increase in CD62+MP (p = 0.0079) and of CD144+MP was detected (p = 0.0315) at high altitudes. No significant difference in any MP level or oxidative stress markers were found between the treatment and the control group. CONCLUSION Hypobaric hypoxia is associated with increased oxidative stress and induces a significant increase in CD62+ and CD144+MP, whereas phosphatidylserine+MP and CD31+MP remain unchanged. This indicates that endothelial activation rather than an apoptosis is the primary factor of hypoxia induced endothelial dysfunction.
dc.description.numberOfPages10
dc.description.sponsorshipDepartement Klinische Forschung (DKF)
dc.description.sponsorshipDepartement Klinische Forschung, Forschungsgruppe Pneumologie (Erwachsene)
dc.description.sponsorshipUniversitätsklinik für Intensivmedizin
dc.description.sponsorshipUniversitätsklinik für Pneumologie
dc.description.sponsorshipUniversitätsinstitut für Klinische Chemie (UKC)
dc.identifier.doi10.7892/boris.76862
dc.identifier.pmid26820158
dc.identifier.publisherDOI10.1007/s00421-015-3309-3
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/138705
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEuropean journal of applied physiology
dc.relation.issn1439-6319
dc.relation.organizationDCD5A442C26EE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BB14E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BADDE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD18E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BA49E17DE0405C82790C4DE2
dc.subjectEndothelial dysfunction
dc.subjectExtreme altitude
dc.subjectHypoxia
dc.subjectMicroparticles
dc.subjectOxidative stress
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleIncreased endothelial microparticles and oxidative stress at extreme altitude.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage748
oaire.citation.issue4
oaire.citation.startPage739
oaire.citation.volume116
oairecerif.author.affiliationUniversitätsklinik für Pneumologie
oairecerif.author.affiliationUniversitätsinstitut für Klinische Chemie (UKC)
oairecerif.author.affiliationDepartement Klinische Forschung (DKF)
oairecerif.author.affiliationDepartement Klinische Forschung, Forschungsgruppe Pneumologie (Erwachsene)
oairecerif.author.affiliationUniversitätsklinik für Intensivmedizin
oairecerif.author.affiliation2Universitätsklinik für Pneumologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId76862
unibe.journal.abbrevTitleEUR J APPL PHYSIOL
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
art%3A10.1007%2Fs00421-015-3309-3.pdf
Size:
629.77 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections